In today’s rapidly evolving social landscape, Ella Robertson stands at the forefront of progressive activism as the Managing Director of One Young World. Under her leadership, the organization has sought to redefine the parameters of effective advocacy, emphasizing action over mere online engagement.  One Young World has long been recognized for convening young leaders from […]

Anavex Life Sciences has announced encouraging findings from a long-term Phase 2 extension study involving its lead drug candidate, ANAVEX®2-73 (blarcamesine).  Anavex Life Sciences’ study focused on patients with Parkinson’s disease dementia (PDD) over 48 weeks and demonstrated significant clinical benefits.  According to Anavex, the study successfully met both its primary and secondary objectives. Participants […]